
Climate change is disrupting the human gut in a new path to illness
Climate-driven food shortage and undernourishment could affect the composition of the human gut microbiota, exacerbating the effects of climate change on human health, according to a new review article published in The Lancet Planetary Health.
The article comes on the heels of a growing number of studies that highlight the key role food and nutrition play in maintaining a healthy microbial population in the human gut, leading to better metabolic and intestinal health.
Diversity disrupted
According to the review, climate-induced changes in the yield and nutritional quality of plants, seafood, meat, and dairy could disrupt this microbial diversity, tipping the balance towards microbial strains associated with malnutrition and particular diseases.
The review also warns that these effects will be more pronounced in low and middle-income countries (LMICs) since these regions face the brunt of climate stressors, including higher temperature and atmospheric carbon dioxide, which affect their agricultural output and increase render deficiencies in these areas more common.
Indigenous communities that depend more than other demographic groups on local food sources and which have been shown to have greater gut microbial diversity may also be more susceptible to climate-related changes, the review reads.
Research has already found that high atmospheric carbon dioxide levels can diminish the quantity of plant micronutrients like phosphorus, potassium, zinc, and iron, along with protein concentrations in vital crops such as wheat, maize and rice. These effects add to the complexities that affect the gut microbiota.
While the effects of food and nutrition are direct, the review also examined the role of changes in water, soil, and other environmental microbiota as a result of climate change.
A fine balance
In another recent review, published in Dialogues in Health, researchers from the Indian Institute of Public Health, Gandhinagar, analysed the impact of heat on human and animal health in India. They found that reports of foodborne and waterborne infectious diseases and malnutrition increase with heat.
Although these findings mirror common knowledge about food and water-related illnesses in warmer weather, the resulting implications for gut dysbiosis — the imbalance in gut microbial populations — also need to be considered for future heat-related mitigation efforts, The Lancet review said.
'While we know and research various effects of climate change on human health, one aspect remains understudied — the effects of changing climate on the microbial communities in the human gut,' Elena Litchman, author of the review in The Lancet and the MSU Foundation professor of aquatic ecology at Michigan State University, said. 'This, in part, could be explained by the fact that researchers studying human microbiota do not necessarily think about it in a climate change context.'
The human gut is home to about 100 trillion bacteria, fungi, protozoa, and viruses. Bacteria are this group's predominant members. The microbes' overall diversity in the gut influences several aspects of human well-being, including immunity, maintaining glucose levels, and metabolism.
According to a 2018 analysis in The BMJ, lower bacterial diversity has been observed in atopic eczema, types I and II diabetes, and inflammatory bowel disease, among other conditions. Researchers are also exploring how gut dysbiosis changes the central nervous system and leads to neurological disorders.
More research attention
The gut microbiome — the collective genome of the microbes in the gut — has far more genes than the human genome, producing thousands of metabolites that affect the individual's health and development.
'Our understanding of the gut microbiota's role in human health is still evolving,' While climate change is a growing concern in this context, establishing cause and effect is difficult as there are many confounding factors,' Sachit Anand, a paediatric urologist and assistant professor at AIIMS, New Delhi, said. In his research, Anand examines the role of gut microbiota in congenital anomalies of the kidney and urinary tract.
He added that understanding the interactions between the microbiota, the host, and the environment is now gaining more research attention, especially when evaluating an individual's susceptibility to specific diseases. As climate change becomes a key influencing factor in this 'triad', its impact cannot be ignored moving forward, he said.
It may be tempting to examine these interdependencies in a linear manner: i.e. that climate-induced changes in crops affect the diet and thus the gut microbiota, or that climate-induced increases in temperatures make enteric infections more prevalent, ultimately disrupting the gut's microbial population. But both Litchman and Tarini Shankar Ghosh, assistant professor at Indraprastha Institute of Information Technology Delhi, warned that many of these stressors are often playing out simultaneously.
As a computational biologist, Ghosh is interested in patterns in data about the human gut microbiome.
'If you take the example of low-income groups residing in urban environments, you are looking at the impacts of temperature, pollution, lack of quality food, and water supply,' he explained. 'There are multiple factors that are disrupting the gut microbiota at the same time.'
A new science
Ghosh also said dysbiosis has been found to be a diagnostic signature in many disease states. According to him, this means it is not just the tipping of the balance towards unfavourable microbial populations that is concerning: dysbiosis also signals a loss of interdependence between 'normal' microbial strains, leading to a loss of several metabolic functions in the host.
'What we need right now is to generate more data to understand how the so-called good bacteria interact with each other and benefit the host. Data generation must go hand-in-hand with connecting this information to climate change, so we know what is happening,' Ghosh said.
Thus, Litchman said, a multidisciplinary approach with researchers from disparate fields coming together is vital to understand the effects of climate change on human gut microbiota. But along with a lack of awareness of climate change's effects, a paucity of funding programmes to enable such interdisciplinary and international research is a major impediment to future research of this nature, she added.
On the flip side, with advances in computational biology and metagenomics — analyses of the genetic makeup of microorganisms in a given environment — researchers are inching closer to unearthing some of the gut microbiota's secrets. For example, Indian Institute of Science Education and Research, Bhopal, professor Vineet Kumar Sharma has developed an open-access database named GutBugBD. It provides information about how the gut microbiome can interact with and alter specific nutraceuticals and drugs, paving the way for therapeutic approaches to modulate gut microbiota in response to various changes.
This is just the start, according to Sharma: 'At the moment, we are merely doing broader surveys of the gut microbiota to understand what is there and how they are functioning. Even if we introduce healthy microbiota through, say, probiotics, we cannot know if the response will be the same between two individuals. Each person's gut microbiota is unique, and understanding this uniqueness is important for the way forward.'
Sharmila Vaidyanathan is an independent writer from Bengaluru.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


United News of India
a day ago
- United News of India
How Vollsante Is Making Plant-Based Nutrition Mainstream
Mumbai (Maharashtra) [India], June 20: The world today, reeling under an epidemic of chronic diseases, is increasingly realizing the impact of dietary choices that affect not only human health but also environmental health. Our food system initially focused too much on output at the expense of human and environmental health and has faced widespread backlash in the wake of the increasing burden of diet-related chronic diseases and co-morbidities. As per a study published in The Lancet, about one in five deaths globally were attributed to diet-related chronic diseases. While plant-based diets are associated with lower risks of chronic diseases, they are being increasingly acclaimed as a better alternative to animal-based diets in the wake of the environmental sustainability crisis facing our planet as plant-based diets have both – a lower carbon footprint and lower water footprint than animal-based diets; producing 1 kg of meat requires 10 times more water than producing 1 kg of wheat. Today, many large urban and affluent individuals are overfed but undernourished. Despite the advent of newer modern medicines, the epidemic of diet-related chronic diseases remains unimpeded. Prof. Satya Dev Tiwari, who had worked with Pharma MNCs for 2 decades, later as faculty at NMIMS School of Business Management, became a devout believer in `Food as Medicine' and `Nutritional Medicine.' On a mission to integrate Food & Nutrition into healthcare with a focus on bringing plant-based diet & nutrition into the mainstream through its distinctive range of Functional Foods & Nutraceuticals, Satya went on to found Voll Sante Functional Foods & Nutraceuticals Pvt. Ltd. in July 2017. Voll Sante's product philosophy has been rooted in twin concepts of `Food is Medicine' and `Nutritional Medicine' that focus on correcting macro & micro-nutrient deficiencies seen as one of the root causes of various diseases, unlike conventional medicine that treats symptoms with synthetic drugs and surgery. Accordingly, Voll Sante is serving the growing plant-based diet & healthier snacking market with its range of tastier plant-based protein supplements such as Voll Pro Protein bars with added probiotics, prebiotics, and herbs besides more delicious and healthier millet-based cookies, savories, muesli and even superfruit-based amla barfi (a rich source of Vitamin C) for those with a sweet tooth. What distinguishes Voll Sante is its impressive portfolio of Plant-based Nutraceuticals viz. Algae-based calcium supplement under the brand Calgal Plus. When most calcium supplements are derived from rocks, shells, or bones – sources that are not only poorly absorbed and may contain heavy metals but also unsuitable for vegetarians, Voll Sante chose instead to formulate Calgal Plus using red marine algae harvested from the pristine waters near Iceland and southern Ireland. This natural source offers calcium in a highly bioavailable form. Not only is Calgal Plus sourced right, but it is formulated better with vegetarian sources of Vitamin D3, Magnesium, and Vitamin K2-7, which work synergistically to ensure calcium is absorbed properly and directed to where it's actually needed – into the bones, rather than settling in arteries or soft tissues. This approach not only strengthens skeletal health but also reduces the risk of vascular calcification, a common concern with conventional calcium supplements. Calgal Plus – the country's top prescribed algal calcium supplement with a higher bioavailability and body-friendlier calcium source with USFDA GRAS status is Benefic, Balanced & Beyond Calcium. Likewise, Voll Pro plant-protein powder is formulated with specified ingredients having supportive roles in fertility, pregnancy, and respiratory illnesses, including. Tuberculosis. Voll Sante is a registered Ni-Kshay Mitra under `Pradhan Mantri TB Mukt Bharat Abhiyaan' and regularly supports non-affording TB patients with its nutritional products free of cost. Voll Sante's functional Oils of Black seed, Pumpkin seed, Moringa seed, Fenugreek, Turmeric, Ginger, and Garlic, filled in 100% vegetarian HPMC capsules, are rich sources of phytonutrients. The structural complexity and molecular diversity of plant-based specialized metabolites make them potential drug-like candidates and often safer than synthetic pharmaceuticals. Many phytonutrients have been linked to various health benefits in humans, including reduced risk of chronic diseases like heart disease, cancer, and diabetes, and also helpful in bone & joint health, building immunity, managing stress, sleep, virility, vitality, and improving cognitive function. The real challenge was to introduce plant-based nutrition to the mainstream. To address this, Voll Sante has been innovative in its product development, creating tastier and more convenient on-the-go formats. These products are accessible through non-traditional channels for both healthcare professionals and consumers. Voll Sante's flagship campaign AHWAN (Actioning for Health & Wellness through Awareness of Nutrition), involving leading Dietitians as influencers, started targeting corporations, Hospital cafeterias, Colleges & Universities as well as Government channels to enhance reach, awareness, recommendation, and active consideration of plant-based nutrition. Voll Sante, on a mission to make plant-based nutrition mainstream, is devoted to Full Health, Full Life for a healthier, happier world in harmony with a more sustainable future – Good for consumers, Good for farmers, and Good for the planet.


The Hindu
3 days ago
- The Hindu
Study of gut genomes finds how antibiotic resistance can differ between genders
A recent study analysing gut genomes found that trends of antibiotic resistance differ between genders. For instance, in high-income countries, women may have more antibiotic-resistant genes, while in low- and middle-income countries, men may have more. Led by researchers at the University of Turku, Finland, the study analysed over 14,600 gut genomes from across 32 countries, taken from a publicly available dataset. Study findings Antibiotic resistance, in which infection-causing germs become immune to the drugs designed to kill them, is a significant public health challenge and is estimated to claim over 39 million lives in the next 25 years, a study published in The Lancet journal in September 2024 said. Furthermore, differences in antibiotic resistance related to gender were found to emerge in adulthood. "This suggests that lifestyle, biological differences or healthcare-related factors may influence these differences more in adulthood than in childhood," author Katariina Parnanen, a postdoctoral researcher at the University of Turku said. "We observed that the association between ARG (antibiotic resistant gene) load and gender was inverted between HICs (high-income countries) and LMICs (low- and middle-income countries): women had higher ARG load in HICs and lower ARG load in LMICs than men," the authors wrote in the study published in the journal npj biofilms and microbiomes. The findings also reveal that in high-income countries, women had an average of nine per cent higher amount of genes related to antibiotic resistance compared to men. Women may be more frequently exposed to antibiotics, bacteria resistant to antibiotics, or are more often carriers of resistant bacteria, the researchers suggested. Additionally, women in these countries were found to have a slightly higher diversity of antibiotic resistance genes compared to men, suggesting a broader variation in resistance in the gut microbiomes, the team said. "Understanding gender differences in antibiotic resistance is key to designing equitable and effective healthcare interventions. Our study will lay the groundwork for further research to reduce health inequalities related to antibiotic resistance," Parnanen said. The researchers also found a strong association between age and country of residence and the number and diversity of genes involved in antibiotic resistance. These were particularly high in infants and the oldest age group, they said. High antibiotic use was associated with higher resistance gene loads and greater diversity. High levels of resistance were also found in low-income countries, which may be explained by factors such as poor hygiene and sanitation, the team said. "Our data-driven analyses shed light on global, gendered antibiotic resistance patterns, which may help guide further research and targeted interventions," the authors wrote. The study used data publicly available from datasets 'Sequence Read Archive' (SRA) and European Nucleotide Archive (ENA).


Time of India
13-06-2025
- Time of India
Air pollution exposure alters fetal brain development
London: Brain development in the womb is affected by the mother's level of exposure to air pollution, researchers have found, although it's not clear whether the brain structure differences observed will cause any issues later. Researchers in Barcelona analyzed data collected between 2018 and 2021 from 754 mother-fetus pairs. During the third trimester of pregnancy, participants underwent transvaginal neurosonography, a specialized ultrasound that allows the analysis of fetal brain shape and structures. Higher prenatal exposure to nitrogen dioxide, particulate matter, and black carbon in pregnant women's homes, workplaces, and commuting routes was associated with an increase in the volumes of multiple brain regions that contain cerebrospinal fluid, the researchers reported in The Lancet Planetary Health. Higher exposure to black carbon was also linked with a reduction in the depth of a groove in the brain called the lateral sulcus, which the researchers said might suggest less maturation of the brain. All measurements of brain structures were within the range considered normal, however. "At this stage, we can only report having observed differences in the brains of fetuses with higher exposure to pollution compared to those with lower exposure," senior study author Jordi Sunyer of the Barcelona Institute for Global Health said in a statement. "Additional research is needed to determine whether these effects are reversible after birth or if they persist, and whether they have any implications for neurodevelopmental outcomes in later stages." SCIENTISTS DISCOVER HOW COMMON PAINKILLER REALLY WORKS Scientists have been wrong about how acetaminophen eases pain, a discovery that could lead to new pain management approaches, researchers reported in PNAS. For decades, scientists believed that acetaminophen, the main ingredient in Tylenol - known in some countries as paracetamol - relieved pain by working only in the brain and spinal cord. But researchers have discovered the drug also works outside the brain, in the nerves that first detect pain. After the drug is ingested, the body processes it into a metabolite called AM404. The new study found in laboratory experiments that AM404 is produced in pain-sensing nerve endings, where it shuts off specific channels that help transmit pain signals to the brain. By blocking these sodium channels, AM404 stops the pain message before it even starts, the researchers said. "This is the first time we've shown that AM404 works directly on the nerves outside the brain," study leader Alexander Binshtok of Hebrew University in Israel said in a statement. "It changes our entire understanding of how paracetamol fights pain." The discovery could lead to new types of painkillers that mimic the effects of AM404, the researchers suggested. Because AM404 targets only the nerves that carry pain, such drugs may avoid some of the side effects of traditional painkillers, they said. RARE APPENDIX CANCERS SPIKE AMONG GEN X, MILLENNIALS U.S. appendix cancer rates, while still low, have been climbing dramatically in younger adults, according to a report published in Annals of Internal Medicine. Appendix cancer rates were three times higher among people born between 1975 and 1985, and four times higher among those born between 1981 and 1989, than among people born in the 1940s, based on national U.S. population data. The conclusions are drawn from the nearly 4,900 adults who were diagnosed with appendix cancer in the United States between 1975 and 2019. The pattern of increasing cancer rates held true, to varying degrees, for all tumor types, including nonmucinous, mucinous, goblet cell, or signet ring cell carcinoma, the researchers said. Rates of colon cancers and other gastrointestinal malignancies have also been rising in younger adults, for reasons that remain unclear, the researchers noted. "It really struck our curiosity... Would we observe similar patterns in rare appendiceal cancers?" said study leader Dr. Andreana Holowatyj of Vanderbilt University Medical Center in Nashville, Tennessee. "And certainly the answer was yes," "The big question remains as to why is this happening," she added. "But what's most important is that as these higher-risk birth cohorts continue to age, it's likely these rates will continue to increase." (To receive the full newsletter in your inbox for free sign up here)